Company Filing History:
Years Active: 2011-2015
Title: Dieter Scheller: Innovator in Dopamine Therapy
Introduction
Dieter Scheller is a notable inventor based in Neuss, Germany. He has made significant contributions to the field of medicine, particularly in the treatment of diseases that respond to dopamine or dopamine agonists. With a total of 6 patents to his name, Scheller's work has the potential to impact many lives.
Latest Patents
Scheller's latest patents include a method of treating diseases that respond to therapy by dopamine or dopamine agonists. This invention relates to a medicament containing (S)-2-N-propylamino-5-hydroxytetralin, which is suitable for treating dopa-sensitive movement disorders. Another significant patent involves the use of rotigotine for the treatment of depression. This invention focuses on the use of rotigotine and its prodrugs and pharmaceutically acceptable salts for producing a pharmaceutical agent aimed at treating depression.
Career Highlights
Dieter Scheller is currently associated with UCB Pharma GmbH, where he continues to innovate in the pharmaceutical field. His work has garnered attention for its potential applications in treating various neurological and psychological conditions.
Collaborations
Scheller has collaborated with notable colleagues, including Klaus Hansen and Alexander Breidenbach. These partnerships have likely contributed to the advancement of his research and the successful development of his patents.
Conclusion
Dieter Scheller's contributions to the field of dopamine therapy highlight his innovative spirit and dedication to improving medical treatments. His patents reflect a commitment to addressing significant health challenges, making him a key figure in the pharmaceutical industry.